MYOKARDIA INC's ticker is MYOK and the CUSIP is 62857M105. A total of 242 filers reported holding MYOKARDIA INC in Q3 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $167,004,000 | +97.5% | 1,225,000 | +40.0% | 1.16% | +70.6% |
| Q2 2020 | $84,543,000 | +319.4% | 875,000 | +103.5% | 0.68% | +291.3% |
| Q1 2020 | $20,158,000 | -86.5% | 430,000 | -79.0% | 0.17% | -82.8% |
| Q4 2019 | $149,414,000 | +41.1% | 2,050,000 | +1.0% | 1.01% | +26.0% |
| Q3 2019 | $105,885,000 | +5.6% | 2,030,397 | +1.5% | 0.80% | +22.7% |
| Q2 2019 | $100,280,000 | -1.1% | 2,000,000 | +2.5% | 0.65% | -14.5% |
| Q1 2019 | $101,395,000 | +29.7% | 1,950,278 | +21.9% | 0.76% | +33.2% |
| Q4 2018 | $78,190,000 | -21.7% | 1,600,278 | +4.5% | 0.57% | -2.9% |
| Q3 2018 | $99,839,000 | +35.8% | 1,531,278 | +3.4% | 0.59% | +30.0% |
| Q2 2018 | $73,545,000 | +45.0% | 1,481,278 | +42.5% | 0.45% | +29.3% |
| Q1 2018 | $50,717,000 | +39.5% | 1,039,278 | +20.3% | 0.35% | +19.0% |
| Q4 2017 | $36,363,000 | +113.5% | 863,732 | +117.3% | 0.30% | +95.4% |
| Q3 2017 | $17,033,000 | – | 397,500 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 399,360 | $54,445,000 | 40.54% |
| Copernicus Capital Management, LLC | 42,186 | $5,751,000 | 5.48% |
| Casdin Capital, LLC | 870,000 | $118,607,000 | 5.31% |
| Foresite Capital Management IV, LLC | 126,492 | $17,245,000 | 3.89% |
| Avoro Capital Advisors LLC | 1,885,000 | $256,982,000 | 3.65% |
| RTW INVESTMENTS, LP | 936,931 | $127,732,000 | 3.08% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 65,859 | $8,979,000 | 2.90% |
| Perceptive Advisors | 1,395,017 | $190,183,000 | 2.78% |
| Fernwood Investment Management, LLC | 38,547 | $5,255,000 | 2.48% |
| Grace Capital | 23,400 | $3,190,000 | 2.47% |